Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCs
Homar Francesc, Lozano Virginia, Martínez-Gómez Juan, Oyagüez Itziar, Pareja Antonio, Payeras Antoni, Serrano Joaquín, Carratalá Carmen, Casado, Casado Miguel